Related references
Note: Only part of the references are listed.Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat
Stephanie Kraemer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Mammalian target of rapamycin inhibition halts the progression of proteinuria in a rat model of reduced renal mass
Fritz Diekmann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
High sirolimus levels may induce focal segmental glomerulosclerosis de novo
Emmanuel Letavernier et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Parietal podocytes in normal human glomeruli
Jean Bariety et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy
Katja Keller et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP
Fangxia Guan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
VEGF-C promotes survival in podocytes
R. R. Foster et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
Sirolimus-associated heavy proteinuria in a renal transplant recipient: Evidence for a tubular mechanism
L Straathof-Galema et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients
M Boratynska et al.
TRANSPLANTATION PROCEEDINGS (2006)
Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus
V Bumbea et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys
H Sartelet et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing
PA Senior et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy
RGB Bonegio et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus
H Skhiri et al.
TRANSPLANT INTERNATIONAL (2005)
Antileukemic activity of rapamycin in acute myeloid leukemia
C Récher et al.
BLOOD (2005)
The Wt1+/R394W mouse displays glomerulosclerosis and early-onset renal failure characteristic of human Denys-Drash syndrome
F Gao et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction
F Diekmann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling
TB Huber et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience
E Morelon et al.
TRANSPLANTATION PROCEEDINGS (2003)
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
M Guba et al.
NATURE MEDICINE (2002)
Share Paper
